Nektar Therapeutics (NKTR) Receivables (2016 - 2025)
Historic Receivables for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $200000.0.
- Nektar Therapeutics' Receivables changed N/A to $200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $200000.0, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 3548.39% down from last year.
- Per Nektar Therapeutics' latest filing, its Receivables stood at $200000.0 for Q3 2025.
- In the past 5 years, Nektar Therapeutics' Receivables registered a high of $30.2 million during Q1 2022, and its lowest value of $200000.0 during Q3 2025.
- Over the past 5 years, Nektar Therapeutics' median Receivables value was $5.1 million (recorded in 2022), while the average stood at $11.5 million.
- In the last 5 years, Nektar Therapeutics' Receivables crashed by 9008.93% in 2023 and then skyrocketed by 2076.79% in 2024.
- Over the past 5 years, Nektar Therapeutics' Receivables (Quarter) stood at $23.9 million in 2021, then tumbled by 72.04% to $6.7 million in 2022, then plummeted by 74.48% to $1.7 million in 2023, then plummeted by 35.48% to $1.1 million in 2024, then crashed by 81.82% to $200000.0 in 2025.
- Its last three reported values are $200000.0 in Q3 2025, $1.1 million for Q4 2024, and $1.2 million during Q2 2024.